RETISERT J Code: J7311

Drug & Product Overview

HCPCS Descriptor Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg

HCPCS Added Date January 1, 2007

Manufacturer Bausch Health

Route of Administration Intravitreal

Generic Status Single-Source; Branded

Dosage Form Implant

About RETISERT

Retisert is a medication aligned to the HCPCS J Code: J7311 for billing, pricing, and reimbursement purposes in the United States. This Ophthalmology medication is administered via the intravitreal route and manufactured by Bausch Health.

Manufacturers, reach out to us to add more information.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
24208-0416-01	Retisert	Bausch & Lomb Americas Inc.	59	0.59 MG

Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

RETISERT Pricing & Reimbursement

J7311 Private Payer Reimbursement

$339.05 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q3 2026

RETISERT CPT Administration Codes

CPT Code	Description
67027	Implantation of intravitreal drug delivery system, includes concomitant removal of vitreous

Not on the CMS JW / JZ list

CMS does not include Retisert (J7311) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J7311. Wastage billing guide →

RETISERT Medically Unlikely Edits (MUE)

The most billing units of J7311 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 0.01 mg.

Practitioner Office & Hospital Outpatient

118 units / day

= 1.18 mg per day

MAI 2 · Date of Service Edit: Policy. Absolute per-day limit set by policy or regulation; units above it are not payable, and denials are not appealable on medical-necessity grounds. See all MUE limits →

RETISERT Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

chronic non-infectious uveitis affecting the posterior segment of the eye

Drug Class

Corticosteroid Hormone Receptor Agonists [MoA]Corticosteroid [EPC]

Frequently Asked Questions

Is there an available Retisert billing and coding guide?

Billing and coding information for RETISERT can be found through Bausch Health. Visit Here →

Are there any available Retisert patient assistance programs?

RETISERT patient assistance information can be found through Bausch Health. Visit Here →

Where can I find Retisert prescribing information?

RETISERT prescribing information can be found at the link below: Visit Here →

Where can I find Retisert side effect information?

Our team has not yet identified a source of side effects information for RETISERT. Please check back in a few weeks.

Does billing RETISERT require JZ/JW wastage modifiers?

CMS does not include RETISERT (J7311) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J7311. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.